Related references
Note: Only part of the references are listed.Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
Tae Hyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Resveratrol stabilized gold nanoparticles enable surface loading of doxorubicin and anticancer activity
Ranjeet Kumar Mohanty et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity
Debariya Dutta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Topoisomerase II-Targeting Properties of a Grapevine-Shoot Extract and Resveratrol Oligonners
Simone A. Baechler et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats
Manar Hamed Arafa et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2014)
Oxidative metabolism enhances the cytotoxic and genotoxic properties of the soy isoflavone daidzein
Simone A. Baechler et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
Fang Huang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
ACS CHEMICAL BIOLOGY (2013)
Resveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient
Daniel Raederstorff et al.
RESVERATROL AND HEALTH (2013)
Anthocyanins suppress the cleavable complex formation by irinotecan and diminish its DNA-strand-breaking activity in the colon of Wistar rats
Melanie Esselen et al.
CARCINOGENESIS (2013)
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
Abdel-Moneim M. Osman et al.
CANCER CELL INTERNATIONAL (2012)
Resveratrol acts as a topoisomerase II poison in human glioma cells
Stefano Leone et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
A. M. Al-Abd et al.
CELL PROLIFERATION (2011)
Resveratrol Oligomers Isolated from Carex Species Inhibit Growth of Human Colon Tumorigenic Cells Mediated by Cell Cycle Arrest
Antonio Gonzalez-Sarrias et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Inhibitory Effects of Resveratrol and Pterostilbene on Human Colon Cancer Cells: A Side-by-Side Comparison
Wasamon Nutakul et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Ketan R. Patel et al.
CANCER RESEARCH (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients
Sergio Granados-Principal et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Resveratrol: Its Biologic Targets and Functional Activity
Shazib Pervaiz et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Delphinidin Modulates the DNA-Damaging Properties of Topoisomerase II Poisons
Melanie Esselen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
Elizabeth D. Brookins Danz et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells
M. Emilia Juan et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
DNA topoisomerase II, genotoxicity, and cancer
A. Kathleen McClendon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines
Angeles Gomez-Martinez et al.
MOLECULAR CANCER RESEARCH (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system
Ho Lun Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide
H Mizutani et al.
LIFE SCIENCES (2005)
Catalytic topoisomerase II inhibitors in cancer therapy
AK Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
